SANTALENSYNTHASE

European patent · EP3589644 · In force

Register entry

Publication number
EP3589644
Application number
EP18718646
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 2, 2018
Published
Jan 8, 2020
Granted
Feb 1, 2023
Protection ends at the latest
Mar 1, 2038
Next annual fee due
Mar 31, 2027
IPC classes
C07K 14/415 (2006.01)
C12N 9/50 (2006.01)
C12N 9/88 (2006.01)
Priority
NL 2018457 02.03.2017
PCT application
PCT/NL2018/050130 02.03.2018
PCT publication
WO2018/160066 07.09.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Dec 13, 2023

    Change

    Published in Swissreg on 13.12.2023

  5. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  6. Feb 1, 2023

    Granted

    Published in Swissreg on 01.02.2023

Parties

Holder

Isobionics B.V.

Urmonderbaan 22, 6167 RD Geleen, NL

Inventor

BEEKWILDER, Martinus Julius

NL-6871 WG Renkum, NL

LENTZEN, Georg Friedrich

6167 RD Geleen, NL

WISSELINK, Hendrik Wouter

4105 AE Culemborg, NL

VAN HOUWELINGEN, Adèle Margaretha Maria Liduina

6733 BR Wekerom, NL

BOSCH, Hendrik Jan

6708 NA Wageningen, NL

MELILLO, Elena

6167 RD Geleen, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.